ASTEX PHARMACEUTICALS Trademark
ASTEX PHARMACEUTICALS is a USPTO trademark filed by Astex Therapeutics Limited. Status: Pending.
Trademark Facts
| Mark | ASTEX PHARMACEUTICALS |
|---|---|
| Serial Number | 79432260 |
| Status | Pending |
| Filing Date | 2025-07-18 |
| Mark Type | Combined |
| Nice Classes | 009 (Electronics & Software), 042 (Software & IT), 044 (Medical Services) |
| Owner | Astex Therapeutics Limited |
| Attorney of Record | Carole E. Klinger |
| Prosecution Events | 13 |
| Latest Event | TEME on 2026-04-08 |
Goods & Services
Class 009: Recorded and downloadable computer software used for drug discovery in the field of drug discovery research and pharmaceutical drug development; recorded and downloadable computer software used for biotechnology research in the field of drug discovery and pharmaceutical drug development; recorded and downloadable computer software used for scientific analysis in the field of drug discovery and pharmaceutical drug development; recorded and downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in drug discovery, biotechnology research and scientific analysis in the field of drug discovery and pharmaceutical drug development; recorded and downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in drug discovery, biotechnology research and scientific analysis; recorded and downloadable computer programs and software algorithms for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, natural language human-machine interfaces and predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of drug discovery, biotechnology research and scientific analysis; Class 042: Pharmaceutical drug development services; drug discovery services; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development; providing scientific health care research information in the field of pharmaceuticals and clinical trials; research and development in the field of pharmaceuticals; Class 044: Providing health care information via telephone and the internet; providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals.
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-02-05 | IB-Processed Transaction | MID |
| 2026-01-20 | IB-1rst Refusal Note | MOC |
| 2025-12-16 | Non-Final Action - Full Refusal | MNFFR |
| 2025-12-16 | XSearch Search Summary | XSS |
| 2025-11-20 | IR-Rep Change | MI9 |
| 2025-09-15 | Filing Receipt Trademark Application | FRC |
USPTO Refusals on Record
- disclaimer_required
- indefinite_identification
- mark_description_required